Supplementation with L-arginine does not influence arterial blood pressure in healthy people: a randomized, double blind, trial.

BACKGROUND AND OBJECTIVES It cannot be excluded that supplementation with L-arginine, by improving function of endothelium and hypotensive effect, can be advantegeous in prevention of cardiovascular diseases in healthy people. However, reports about hypotensive effect of L-arginine in healthy people are unclear. Moreover, no research including ambulatory blood pressure measurement (ABPM) has been conducted so far. Therefore, the aim of our study was to show if 4-week supplementation of healthy people with L-arginine influences blood pressure measured with ABPM. MATERIALS AND METHODS The study was carried out on 19 healthy people randomized to 6 g/24-hour, 12 g/24-hours of L-arginine or placebo. ABPM was carried out 4 times: before randomization, after 2 and 4 weeks of supplementation and 2 weeks after finishing supplementation. RESULTS It was found that 4 weeks of supplementation of healthy people with L-arginine (6 or 12 g/24-hour) led to nonsignificant decrease of systolic and diastolic blood pressure; the decrease was greater during night. CONCLUSION These findings showed that supplementation with L-arginine is not necessarily advantageous in healthy people.

[1]  D. Tsikas,et al.  Nitric oxide and hypertension. , 2012, Journal of hypertension.

[2]  G. Brabant,et al.  Oral L-arginine improves endothelial function in healthy individuals older than 70 years , 2003, Vascular medicine.

[3]  S. Chierchia,et al.  Acute Intravenous l-Arginine Infusion Decreases Endothelin-1 Levels and Improves Endothelial Function in Patients With Angina Pectoris and Normal Coronary Arteriograms: Correlation With Asymmetric Dimethylarginine Levels , 2003, Circulation.

[4]  J. Tayek,et al.  Oral Arginine Reduces Systemic Blood Pressure in Type 2 Diabetes: Its Potential Role in Nitric Oxide Generation , 2002, Journal of the American College of Nutrition.

[5]  J. Keaney,et al.  Endothelial function: a barometer for cardiovascular risk? , 2002, Circulation.

[6]  L. Nelin,et al.  L-arginine infusion lowers blood pressure in children. , 2001, The Journal of pediatrics.

[7]  S. Davies,et al.  Clinical presentation and diagnosis of coronary artery disease: stable angina. , 2001, British medical bulletin.

[8]  F. Perticone,et al.  Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients , 2001, Circulation.

[9]  M. Uematsu,et al.  Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. , 2001, American journal of respiratory and critical care medicine.

[10]  B. Žižek,et al.  Endothelial dysfunction in hypertensive patients and in normotensive offspring of subjects with essential hypertension , 2001, Heart.

[11]  J. Whitworth,et al.  Effects of oral l-arginine on plasma nitrate and blood pressure in cortisol-treated humans , 2001, Journal of hypertension.

[12]  L. Iacoviello,et al.  Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. , 2000, American journal of hypertension.

[13]  R. Porat,et al.  Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris. , 1999, The American journal of cardiology.

[14]  S. Higano,et al.  Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. , 1998, Circulation.

[15]  G. Torelli,et al.  L-arginine infusion decreases platelet aggregation through an intraplatelet nitric oxide release. , 1997, Thrombosis research.

[16]  M. Copland,et al.  Basal nitric oxide synthesis in essential hypertension , 1997, The Lancet.

[17]  D. Stewart,et al.  The hypotensive effect of L-arginine is associated with increased expired nitric oxide in humans. , 1996, Chest.

[18]  D. Stewart,et al.  Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension. , 1995, Circulation.

[19]  M. Yoshimura,et al.  Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans. , 1995, The Journal of clinical endocrinology and metabolism.

[20]  A. Barbul,et al.  Metabolic effects of arginine in a healthy elderly population. , 1995, JPEN. Journal of parenteral and enteral nutrition.

[21]  J. M. Hind,et al.  Orall-arginine supplementation has no effect on cardiovascular responses to lower body negative pressure in man , 1994, Clinical Autonomic Research.

[22]  A. Quyyumi,et al.  Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. , 1994, Journal of the American College of Cardiology.

[23]  A. Takeshita,et al.  Effects of L-arginine on forearm vessels and responses to acetylcholine. , 1992, Hypertension.

[24]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[25]  F. Oelze.  [Natural treatment of hypertension]. , 1956, Hippokrates.

[26]  W. J. Visek,et al.  Arginine needs, physiological state and usual diets. A reevaluation. , 1986, The Journal of nutrition.